Share
Blood Grouping Reagents Market Size, Share, and Analysis, By Product (Consumables, Instruments), By Test Type (Blood Group and Phenotype, Antibody Screening, Cross-Matching Tests, Antibody Identification, Coombs Tests, Antigen Typing), By Technique (PCR-Based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, Others), By End User (Hospitals, Blood Banks, Clinical Laboratories) and Regional Forecasts, 2022-2032
Blood Grouping Reagents Market size was USD 1.21 billion in 2021 and projected to grow from USD 1.4 billion in 2023 to USD 2.9 billion by 2032, exhibiting a CAGR of 8.4% during the forecast period.
Blood Grouping Reagents are used to ascertain human antigens of blood group like ABO, Kell, MNS, and Rhesus blood group antigens). The RhD and the ABO blood group systems are the key essential blood groups in blood transfusions. Blood classes are identified by either a protein or a molecule (carbohydrate) like the ABO antigens of blood group or several other antigens on the surface of the human red blood cell.
Blood Grouping Reagents Market is expected to reach USD 2.9 billion, growing at a CAGR of 8.4% during the forecast period owing to the rising demand for blood group typing and blood transfusions and growing cases of emergencies like road accidents. Moreover, the mounting penetration of healthcare and associated facilities is anticipated to boost the growth of the Blood Grouping Reagents Market over the forecast period.
Blood Grouping Reagents Market is classified based on the Test Type into Blood Group and Phenotype, Antibody Screening, Cross-Matching Tests, Antibody Identification, Coombs Tests, and Antigen Typing. The Antibody Screening category is projected to hold major market share over the forecast period. It is widely used for recording disclosure to contagious agents, diagnosing the origin of a transfusion reaction after an organ transplant, measuring immunological status to microorganisms, and monitoring the sluggish advancement of infection or autoimmune illness.
Blood Grouping Reagents Market is classified based on the Technique into PCR-Based and Microarray Technique, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology, and Others. The PCR-Based and Microarray Technique segment is leading the market due to the variety, simplicity, and low cost of in vitro techniques for amplifying specific target RBC polymorphism areas. PCR-based assays are used to identify the antigen kind of donor RBCs for transfusion and antibody identification reagent panels.
Growing Need for Blood Transfusions is Expected to Boost the Market Growth
The need for blood transfusions from patients with thalassemia, liver and kidney illnesses, hemolytic anemia, sickle cell anemia, and hemophilia is fueling the Blood Grouping Reagents Market. Moreover, determining a pregnant woman's fetal blood type is a vital aspect of prenatal care and is commonly done using blood grouping reagents, thereby driving the market. These elements are raising the end user demand for blood-grouping tools, which is boosting the market growth.
Increasing Awareness about the Advantages of Blood Donation is Expected to Boost the Market Growth
People worldwide are becoming more and more aware of the potential advantages of blood donation. Blood donation is also recognized to improve the physical and mental health of donors by lowering stress, enhancing emotional wellbeing, reducing the risk of heart attack and heart disease, and regenerating blood cells. Owing to these considerations, more individuals are donating their blood at clinics, hospitals, and blood banks to assist patients who require transfusions live longer. Hence, the Blood Grouping Reagents Market is witnessing increasing need for items made from blood component parts, including reagents, among end users like clinics, hospitals, and blood banks.
Concerns Regarding Inconsistent Findings May Restrain the Market Growth
Since the COVID-19 epidemic, there has been a noticeable increase in the need for blood grouping reagent examination. The sales of market firms have increased due to the increased use of serology test kits, RT-PCR kits, and blood typing kits. Despite this, a lot of concerns have been made about the unreliable findings obtained after using fast test kits. Quality has been reduced due to the pressing need for a lot of test kits quickly. This had a negative impact on the global Blood Grouping Reagents Market.
Blood Grouping Reagents Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. The growing cases chronic illnesses, increasing aging population, and numerous surgical procedures are projected to fuel the growth of the North America Blood Grouping Reagents Market in the upcoming years. This necessitates the use of blood grouping reagents for precise blood grouping and cross-matching. Moreover, North America is renowned for its cutting-edge technology advancements and healthcare systems. The region has witnessed the implementation of point-of-care testing tools and automated blood type systems, both of which need suitable blood grouping reagents. These developments enhance precision, effectiveness, and patient outcomes.
The entry of the coronavirus had a negative effect on numerous industries worldwide. However, a significant amount of blood grouping reagent items was needed for diagnostic purposes due to the rising number of COVID-19 patients. There is a tremendous global demand for the growing number of assay methods available to determine whether patients have the coronavirus or not. The market players were forced to develop blood grouping reagent items due to the sudden increase in diagnostic procedures.
|
ATTRIBUTE |
DETAILS |
|
Study Period |
2018-2032 |
|
Base Year |
2022 |
|
Forecast Period |
2022-2032 |
|
Historical Period |
2019-2021 |
|
Growth Rate |
CAGR of 8.4% from 2022-2032 |
|
Unit |
Value (USD Billion) |
|
Segmentation |
Main Segments List |
|
Product |
|
|
Test Type |
|
|
Technique |
|
|
End User |
|
|
By Region |
|
Blood Grouping Reagents Market size was estimated at USD 1.21 billion in 2021 and is expected to reach USD 2.9 billion in 2032.
Blood Grouping Reagents are used to ascertain human antigens of blood group like ABO, Kell, MNS, and Rhesus blood group antigens). The RhD and the ABO blood group systems are the key essential blood groups in blood transfusions.
Antibody Screening and PCR-Based and Microarray Technique segments accounted for the largest Blood Grouping Reagents Market share.
Key players: Merck KGaA, Cardinal Health, Beckman Coulter Inc, Bio-Rad Laboratories Inc, Quotient Ltd., Tulip Diagnostics, Diagast SAS, Atlas Medical, Fortress Diagnostics, Alpha Laboratories, BAG Diagnostics GmbH, Haemokinesis Pty Ltd, Aikang, Rapid Labs Ltd, Anamol Laboratories Pvt. Ltd., and Other Prominent Players are the key players in the Blood Grouping Reagents Market.
Growing incidences of chronic disorders and rising demand for blood group typing and blood transfusions are the factors driving the Blood Grouping Reagents Market.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
